We manage every aspect of clinical operations, from site selection and initiation to monitoring and closeout. Our experienced project managers work closely with sponsors to keep trials on schedule and within budget while ensuring strict regulatory compliance. With our proactive approach, we anticipate and solve issues in real time, minimizing delays and keeping trials on track.
Navigating the complex regulatory landscape is vital for any clinical trial's success. Divergent S.P.E.E.D.’s dedicated regulatory team handles submissions and regulatory agency interactions, including with the FDA and EMA. We ensure compliance with international guidelines, efficiently managing submissions to reduce risks of setbacks and delays.
We utilize cutting-edge electronic data capture (EDC) systems to ensure real-time, secure data collection and monitoring. Our biostatistics team applies advanced statistical methodologies to provide reliable, actionable insights that help sponsors make informed decisions throughout the trial lifecycle.
At Divergent S.P.E.E.D., we prioritize quality and regulatory compliance. Our robust quality management systems and regular audits ensure that our trials meet Good Clinical Practice (GCP) standards and all regulatory requirements, safeguarding both patient safety and data integrity.
We develop targeted recruitment strategies to attract suitable participants and ensure their continued engagement throughout the trial. Our patient-centric approach, combined with the use of digital platforms, allows us to address recruitment bottlenecks and accelerate enrollment timelines.
"As a dynamic, full-service CRO, Divergent S.P.E.E.D. provides end-to-end solutions for every phase of clinical trials—from early development to post-marketing surveillance. "
Divergent S.P.E.E.D
Copyright © 2024 Divergent S.P.E.E.D - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.